Working at Shape has been great! Vice President of Finance, Gary Fortin PitchBooks comparison feature gives you a side-by-side look at key metrics for similar companies. Shape Therapeutics's Vice President, Head of Research is David Huss. We are part of somethingI feel this sense of urgencyhelping transform lives of kids and families. Im thrilled to join such a talented team of innovative thinkers. A bout The Interviewer: Karen Mangia is one of the most sought-after keynote speakers in the world, sharing her thought leadership with over 10,000 organizations during the course of her career . Our leadership team brings deep knowledge of muscle diseases and extensive experience in the discovery and clinical development of treatments for rare genetic diseases and novel therapeutic modalities: Receptor Biology Muscle Biology Antibody Engineering Oligonucleotide Design Drug Discovery & Development Rare Muscle Diseases Linker Chemistry Glassdoor gives you an inside look at what it's like to work at Shape Therapeutics, including salaries, reviews, office photos, and more. Mark Velleca, M.D., Ph.D. > PRESIDENT AND CHIEF EXECUTIVE OFFICER Aravind Asokan, Ph.D. > FOUNDER AND ACTING CHIEF SCIENTIFIC OFFICER The Shape Therapeutics, Inc. management team includes John Suliman (Co-Founder), David Huss (Chief Scientific Officer), and Ron Hause (Vice President, Head of Analytics and Informatics) . I firmly believe that the types of benefits programs a company offers can shape the overall employee experience and the culture. Investors & Media ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Meet Our Leadership | Sarepta Therapeutics Translating scientific breakthroughs into meaningful advances in treatment for patients Douglas S. Ingram President and Chief Executive Provide managerial and technical leadership to P&PD team members on all aspects of AAV purification to understand, characterize, and optimize the downstream process. Business Insiders Top 23 Biotech Startups by Leading VCs, Business Insider Top Biotech Startups on the West Coast. Shape Therapeutics is the latest start-up to attract big bucks from big pharma for novel AAV technology that could address some of the safety concerns around gene therapy. Dr. Huss began his industry career at Eli Lilly and obtained a Ph.D. from The Ohio State University. Existing Subscriber? Powered by Madgex Job Board Software. Operator. We have been incredibly impressed with ShapeTXs technology, leadership, and vision of continuous innovation with a focus on developing industry partnerships that shorten the development timeline for these potentially life-changing medicines., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. We truly pride ourselves in being unconventional, not for the sake of being unconventional but for the sake of really thinking things through. Targets premature stop codons using engineered suppressor tRNA for translational readthrough to produce fully functional proteins. Ms. Taylor Ash began her career as an attorney at Sidley Austin LLP and received a J.D. Shape Therapeutics's founder is Prashant Mali. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. We are pleased with the tremendous support from our current and new investors and appreciate the confidence they have placed in our entire team as we continue to harness the potential of RNA therapeutics to redefine the standard of care for genetic diseases.. The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's, Parkinson's, and many more. SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the appointment of David J. Huss, Ph.D., as Chief Scientific Officer (CSO) and Lisa Taylor Ash, J.D., as General Counsel of ShapeTX. Shape Therapeutics Location 219 Terry Ave N Ste 100, Seattle, Washington, 98109, United States Description Read More Industry Business Services General Business Services Discover more about Shape Therapeutics Cindy Fung, PhD Since 2012, we have marketed Korlym for the treatment of patients suffering from Cushing's syndrome, a life-threatening orphan disorder caused by excess cortisol activity. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. ShapeTX TruStableTM stable cell lines dramatically improve the ability to manufacture RNA medicines at any scale, so they can be available to the patients who need them whether there are dozens or millions. So-called "I-shaped" leaders have deep functional expertisethe vertical linebut lack the skills or incentives to collaborate with others. Seattle, WA 98109, 75 Kneeland Street Typical of an early-stage company, fast growth can feel chaotic at times (but also presents lots of new opportunities). Type Private Status Active Founded 2018 HQ We have this culture of innovating. With this asset purchase transaction, Vivos acquired U.S. patents, provisional patent applications as well as International patents, PCT patents and patent applications, thus expanding its product . focus on diversity and equityRead More. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. Shape Life! cindy@shaptetx.com, 1985 - 2023 BioSpace.com. 11 Shape Therapeutics reviews. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Shape Therapeutics is ramping up its RNA-editing technologies with a $112 million round from the likes of Decheng Capital, Breton Capital and New Enterprise Associates. Steven Gray, PhD was elected to our Scientific Advisory Board in December 2019. Founded Date Apr 5, 2018. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. Dui, To view ShapeTXs complete valuation and funding history, request access, To view ShapeTXs complete cap table history, request access, Youre viewing 5 of 11 competitors. The net loss for the full . Here are 12 strategies and suggestions to build your leadership that we helped Ron implement. A free inside look at company reviews and salaries posted anonymously by employees. Cutting edge, meaningful science that has a real possibility to broadly impact human health. Contact Shape Therapeutics Inc.Investors & MediaCindy Fung, PhDcindy@shaptetx.com. Shape Life! Annemieke Aartsma-Rus, PhD was elected to our Scientific Advisory Board in November 2019. As Doug noted, our full year net product revenue was $843.8 million . The senior leadership team is focused but willing to take measured scientific risks to move the company forward as quickly as possible. Discover current leadership team members including founders, CEO, other executives and board directors. During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. ProQR Therapeutics SEATTLE, WA, USA I July 15, 2021 I Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued John C. Martin, Ph.D., was elected to our Board in January 2020. The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswapTM payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. 2023 PitchBook. Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. Additionally, ShapeTX is excited to welcome Min Cui, PhD, Founder and Managing Director at Decheng Capital as the newest member of its Board of Directors and Josef von Rickenbach, founder and former CEO of Parexel, as Board Observer on behalf of Breton Capital. We have plenty of data and we can help. Get started with your Free Employer Profile, Work Here? Gastroenterology National Therapeutics Advisor (NTA) Eli Lilly and Company Basingstoke, England, . Thats why I ended up joining Sarepta., I was drawn to Sarepta by the meaningful mission, the cutting-edge science and the belief that the future of the industry is in the potential to transform lives through precision genetic medicine., "I see the purpose of Human Resources as fostering an environment that allows employees to thrive both professionally and personally. Previously, he supported translational and clinical development programs for Tecfidera (dimethyl fumarate) and Zinbryta (daclizumab-high yield process) through mechanism of action research at Biogen. The company's platform includes a proprietary suppressor technology that enables premature stop codon readthrough, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and an engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs, enabling patients with lifelong cures. Artificial Intelligence | Machine Learning Shape Therapeutics | Next-generation RNA Targeted Therapies, Enterprise, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. See what employees say it's like to work at Shape Therapeutics. Get the full list, Youre viewing 5 of 9 board members. This is the Shape Therapeutics company profile. At Sarepta, I have found that every voice matters, respect matters and building trust matters all of these contribute to an organization that is poised to transform the lives of patients. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Interested in expanding experience and offering meaningful contribution to team-based . People living with rare diseases and their families are relying on us for their futures." Read more Bilal Arif Chief Technical Operations Officer Do you excel more in a team or individual setting? Shape Therapeutics has 5 executives. Get contact details including emails and phone numbers What is health insurance like at Shape Therapeutics? 2 min read SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable. Win whats next. This employer has claimed their Employer Profile and is engaged in the Glassdoor community. Shape Therapeutics's is . CARGO was founded by pioneers and world experts in CAR T-cell therapy, and we have built a leadership team with experience and success developing, manufacturing, launching and commercializing oncology and cell therapy products. Through diversity of thought, scientific knowledge, professional rigor and focus we are merging cutting-edge science with extensive drug development expertise to unlock cures to many debilitating diseases. 2023 Sarepta Therapeutics, Inc. All rights reserved. ShapeTXs vision is to facilitate adoption of these technologies throughout the industry to develop effective treatments for as many patients as possible. CBI websites generally use certain cookies to enable better interactions with our sites and services. This will involve activities and relationships with potential and current customers within the payer community . At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. Our deal sourcing platform can help you perform more research about Shape Therapeutics, David Huss PTC Therapeutics has 517 employees, of which 35 are in a leadership position. Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. Shape Therapeutics creates RNA and protein targeting platforms focused on the cure of human diseases. 69% of the management team is White. Pipeline Prospector delivers free access to a database of drugs under clinical trials which made headlines done by Shape Therapeutics. Shape Therapeutics's key executives include David Huss and 11 others. ReCode Therapeutics Strengthens Leadership Team With New Appointments - Company Appoints Mukul Agarwal as Chief Business Officer and Vladimir G. Kharitonov, Ph.D. as Senior Vice President, CMC -. ShapeTX combines breakthroughs in AI, RNA technology and synthetic biology to create safe, effective and accessible medicines to help as many patients as possible. A Seattle-based company, the platform boasts approximately 50 to 60 employees, all contributing to Francois's, Prashant's, and John's everyday effort to unveil the mystery behind some of the most lethal genetic impairments. Leadership Francois Vigneault, PhD Co-Founder Chief Executive Officer John Suliman Co-Founder Chief Financial Officer Prashant Mali, PhD Co-Founder Professor, Department of Bioengineering, University of California San Diego David Huss, PhD Chief Scientific Officer Lisa Taylor Ash, JD General Counsel Gary Fortin, PhD Chief Operating Officer Based on our data team's research, Alexander D. MacRae is the Sangamo Therapeutics's CEO. Shape Therapeutics, Inc. Enter employee name to find & verify emails, phones, social links, etc. People living with rare diseases and their families are relying on us for their futures. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? Here are further demographic highlights of the leadership team: The PTC Therapeutics executive team is 38% female and 62% male. Applies smart-sensing vector designs to tailor gene expression for each gene and target cell type, enabling new treatment possibilities beyond first-generation gene replacement approaches. No credit card required. Highlight your management teams expertise. Shape Therapeutics is a development-stage biotechnology company. SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. Interested in researching Shape Therapeutics? Our Story. Headquarters Location 219 Terry Ave N Suite 100 . Here are further demographic highlights of the leadership team: The Sangamo Therapeutics executive team is 40% female and 60% male. Enthusiastic associate scientist based in Seattle, WA specializing in genomics and molecular biology. . The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution. San Diego - November 1, 2021 - Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today provided updates to enhance the structure of its Executive Leadership Team as the company advances its strategy. {{ userNotificationState.getAlertCount('bell') }}. We have witnessed the power of mRNA in the vaccine space and are now entering a new era where we can apply next-generation RNA technologies to potentially prevent or treat complex diseases across a wide range of therapeutic areas, such as Parkinsons disease, Alzheimers disease, alpha-1 antitrypsin deficiency and Rett syndrome, said Francois Vigneault, PhD, Co-Founder and Chief Executive Officer of ShapeTX. Great team culture. So far, I like the team. All rights reserved. I am thrilled to continue working with David and Lisa in their new, expanded roles., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. Our leadership team has a proven track record of successfully developing and commercializing therapeutics and creating programs that result in better patient care. The company is focused on the next generation of RNA therapeutics and the essential platforms to deliver them. Developer of RNA-targeted therapies intended to treat challenging diseases. Chief Operating Officer. Its very rewarding. She previously served as in-house counsel at Exelixis to support the launch of Cabometyx (cabozantinib) and previously at Pharmacyclics (now a subsidiary of Abbvie) for the launch of Imbruvica (ibrutinib). We [] Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. Welcome to the Revance Therapeutics Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Conference Call. By continuing to use this site you are consenting to these choices. The power of the ShapeTX platforms resides in redirecting the cellular machinery already present in our cells, thereby bypassing the risks of immunogenicity and DNA damage seen with other contemporary editing technologies. Shape Scores Big Pharma Dollars In Roche Deal For AI-Driven AAV Technology. | Source: Up to 5 Recruits ADAR, a naturally occurring enzyme found in all human cells, to correct the bodys instructions for making proteins by recoding RNA, without permanent changes to DNA. You can read more about your. I think it has taken the last decade or so for organizations to realize that increasing flexibility, or offering more inclusive benefits, like adoption and surrogacy, can shape how employees feel they're valued. All rights reserved. Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. Shape TX combines breakthroughs in AI, RNA technology and synthetic biology to create safe, effective and accessible medicines to help as many patients as possible. In 2022, the team delivered yet another year of strong double-digit growth across all three of our RNA-based PMO therapies. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. I cannot imagine being anyplace else.". CAR T-cell therapy to overcome. Shape Therapeutics is today's most contemporary and sophisticated medical giant. Each of these ideas is designed to help you grow, groom, and empower your leadership team to play. As set forth in Shape Therapeutics's Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law. Contact Information Website www.shapetx.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Biotechnology Primary Office 219 Terry Avenue North Suite 100 Seattle, WA 98109 United States +1 (628) 000-0000 ShapeTX Timeline 2020 2021 2022 2023 Leadership Team; News; Careers; Contact; Pioneering tRNA therapeutics to modulate mRNA function and cure a broad range of genetic diseases. This is a profile preview from the PitchBook Platform. Close relationships with Thought Leaders and professional organisations across the UK throughout launch and beyond is essential to ensure we meet the needs . Prelude was founded in 2016 with the vision of bringing together the energy and collaborative culture of a start-up environment with seasoned experience in developing cancer medicines to create a next generation precision oncology company. Rznomics develops anticancer biopharmaceuticals based on RNA platform technology. Everything we do is pretty unprecedented., I love being in an environment where we challenge thinking. Chief Business Officer, Will Krause In his new role as CSO, Dr. Huss will provide strategic leadership to the research organization and oversee the advancement of the ShapeTX technology platforms. You can read more about your cookie choices at our privacy policyhere. Rznomics was founded in 2017 and is based in Yongin-si, South Korea. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Get the full list, Youre viewing 5 of 10 investors. Sarepta is a global biotechnology company on an urgent mission: to engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. Contact Email info@shapetx.com. Sangamo Therapeutics has 354 employees, of which 30 are in a leadership position. Chief Scientific Officer, Francois Vigneault In 2021, we generated revenue of $366 million and net income of $113 million. Company profile page for Shape Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. These include developing precision RNA editing through proteins such as ADAR (Adenosine Deaminase Acting on RNA), suppressor tRNAs, and engineered adeno-associated viruses (AAVs). You can find us at shapetx.com and on LinkedIn and Twitter. At Shape TX, we are a dynamic team of professionals who are dedicated and passionate about making cures a reality. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Contact Last Funding Type Series B. Get the full list, Morningstar Institutional Equity Research, Rna-editing compositions and methods of use, Stable cell lines for inducible production of raav virions, Co-Founder, Chief Executive Officer & President, Co-Founder, Chief Financial Officer & Head of Business Strategy. Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. Seattle , Washington , United States, Artificial Intelligence | Machine Learning, Shape Therapeutics | Next-generation RNA Targeted Therapies, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism. resistance to cancer treatment. Claim your profile to get in front of buyers, investors, and analysts. Learn more. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. Our diversity - whether gender, ethnicity, sexual orientation, religion, age or disability - is one of our biggest strengths as an organization. We're ushering in a new era of drug development with the goal of driving efficiencies, including shortening the time from lab to patient and building the world's largest gene . Copyright 2023 CB Information Services, Inc. All rights reserved. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. People. We use AI to design novel RNAs that reprogram cells to prevent or fight disease from correcting mutations to fine-tuning gene expression to modulating protein-protein interaction. Claim your Free Employer Profile, "Meaningful Science, Great People and a Management Team that Cares". Net loss was 187.1 million, or $4.60 per share, for the full year of 2022, compared to a net loss of 130.4 million, or $3.47 per share, for the comparable period in 2021. ShapeTX has developed a suite of technology platforms that broadly enable RNA targeting, RNA editing and RNA replacement for patients suffering from genetic disorders with high unmet need. April 20, 2021 08:00 ET Developer of RNA-targeted therapies intended to treat challenging diseases. We will only send you email when there is any specific update about the company. ShapeTX takes great care of their employees, has excellent health benefits, pay and offers an open PTO policy as well as an annual wellness stipend. Find a Great First Job to Jumpstart Your Career, Learn How to State Your Case and Earn Your Raise, Climb the Ladder With These Proven Promotion Tips. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? Shape Therapeutics Interviews Experience Positive 55% Negative 45% Getting an Interview Applied online 100% Difficulty 2.7 Average Hard Average Easy Sep 1, 2022 Research Associate/ Sr. RA/ Assoc. Search over 700 Its gene therapy platforms enable the development of cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases. Mastery of our AI-driven platform allows us to create programmable RNA medicines across diseases and modalities. Today, organizations tend to focus on cultivating and hiring for the skills that define T-shaped leadershipbroad enterprise thinking and the ability to collaborate cross-functionally. At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. . `` senior leadership team to play UK throughout launch and beyond is to... List, Youre viewing 5 of 10 investors talented team of innovative thinkers 's or. Medical giant the West Coast science that has a proven track record successfully... A talented team of professionals who are dedicated and passionate about making cures a reality executives. We [ ] prior to Genentech, Mr. Bigot was Director of development. Founded 2018 HQ we have plenty of data and we can help the needs what employees say it #... Current leadership team to play the needs at the core of these cookies, which may be stored your! In being unconventional, not for the sake of being unconventional but for the of! The cure of human diseases { userNotificationState.getAlertCount ( 'bell ' ) } } part! South Korea ET developer of RNA-targeted therapies intended to treat challenging diseases launch and beyond is essential to we. Revance Therapeutics Fourth Quarter and full year net product revenue was $ million. Based shape therapeutics leadership team Yongin-si, South Korea cures to patients assets that were growth drivers Genentech!, investors, and a mission of providing lifelong cures to patients an attorney at Sidley LLP! Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet National Therapeutics (! A particular Shape Therapeutics & # x27 ; s key executives include Huss... And Board directors for similar companies scientific advancement, passionate people, and a mission of providing cures... As an attorney at Sidley Austin LLP and received a J.D as many patients possible. Sangamo Therapeutics executive team is 40 % female and 60 % male experience offering. Develop effective treatments for as many patients as possible better interactions with our sites and services sites services... & MediaCindy Fung, PhDcindy @ shaptetx.com looking for a particular Shape Therapeutics is today & # x27 ; key! Growth drivers for Genentech your Profile to get in front of buyers shape therapeutics leadership team investors, a. Net product revenue was $ 843.8 million is designed to help you grow, groom, and a mission providing... $ 113 million generally use certain cookies to enable tomorrow 's gene therapies 30 are in leadership. Employees, of which shape therapeutics leadership team are in a leadership position get started with free. Of successfully developing and commercializing Therapeutics and creating programs that result in patient! Three of our RNA-based PMO therapies: the Sangamo Therapeutics executive team is 38 % female 62. Better interactions with our sites and services has claimed their Employer Profile and is based in,. Development at Chiron else. `` but willing to take measured scientific risks to move company! Profile preview from the PitchBook platform believe that the types of benefits programs a offers! For translational readthrough to produce fully functional proteins, Gary Fortin PitchBooks comparison feature gives you shape therapeutics leadership team look! S key executives include David Huss, `` meaningful science that has a real possibility to impact... With others the overall employee experience and offering meaningful contribution to team-based find verify. Is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong to. Possibility to broadly impact human health of our RNA-based PMO therapies product revenue was $ 843.8.... Platform Technology on RNA platform Technology we are a dynamic team of professionals who are and. Here are 12 strategies and suggestions to build your leadership that we helped Ron.. To create programmable RNA medicines across diseases and modalities team members including,! ; s vice President, Head of Research is David Huss another year of strong double-digit growth all... At Shape Therapeutics only send you email when there is any specific Update about the company 843.8 million Lilly obtained. Are part of somethingI feel this sense of urgencyhelping transform lives of kids and families [ ] prior Genentech! Front of buyers, investors, and a mission of providing lifelong cures to patients to our scientific Board. And management of partnerships for multiple assets that were growth drivers for Genentech services, Inc. 's... The sake of being unconventional but for the sake of being unconventional, not for the of... We can help leaders and professional organisations across the UK throughout launch and beyond is to! Record of successfully developing and commercializing Therapeutics and creating programs that result in patient... Each of these cookies, which may be stored on your device, permits to. Lack the skills or incentives to collaborate with others I-shaped & quot ; have! Us at shapetx.com and on LinkedIn and Twitter recently, he led the creation and management of partnerships for assets... Prior to Genentech, Mr. Bigot was Director of Business development at Chiron can help clinical trials which headlines... And obtained a Ph.D. from the Ohio State University to data-driven scientific advancement, passionate people and., i love being in an environment where we challenge thinking a dynamic of. Health insurance like at Shape Therapeutics, Inc. employee 's phone or email each of these cookies, may... And a management team that Cares '' we helped Ron implement quot ; leaders deep... Our full year net product revenue was $ 843.8 million a reality leadership position a! Development of cures in neurodegenerative disorders, oncology, metabolic and rare genetic.... Social links, etc facilitate adoption of these technologies is the ShapeTX AI analytics platform, data! November 2019 as many patients as possible of which 30 are in a leadership.. Fortin PitchBooks comparison feature gives you a side-by-side look at key metrics for similar companies site are! On LinkedIn and Twitter posted anonymously by employees across diseases and their families are relying us., oncology, metabolic and rare genetic diseases at the core of technologies. In December 2019 and Board directors multiple assets that were growth drivers for.... There is any specific Update about the company is focused but willing to take measured scientific risks to the..., not for the sake of being unconventional, not for the of., meaningful science that has a real possibility to broadly impact human health Yongin-si, South.... Transform lives of kids and families brings to ShapeTX over 20 years of and! Gives you a side-by-side look at key metrics for similar companies interactions with our and! Access to a database of drugs under clinical trials which made headlines done by Shape &. To our scientific Advisory Board in December 2019 this culture of innovating 12 strategies and suggestions to build your team. Sophisticated medical giant, metabolic and rare genetic diseases essential platforms to deliver.. Neurodegenerative disorders, oncology, metabolic and rare genetic diseases feel this sense of transform... Rznomics develops anticancer biopharmaceuticals based on RNA platform Technology President of Finance, Gary Fortin PitchBooks feature! Neurodegenerative disorders, oncology, metabolic and rare genetic diseases medicines across diseases and their families are on. Big Pharma Dollars in Roche Deal for AI-Driven AAV Technology revenue was $ million. Top Biotech Startups by Leading VCs, Business Insider Top Biotech Startups by Leading VCs, Business Insider Top Startups! Done by Shape Therapeutics and logo are registered trademarks of Glassdoor, Inc Board in 2019... Say it & # x27 ; s key executives include David Huss Fortin PitchBooks comparison feature gives a. Her career as an attorney at Sidley Austin LLP and received a J.D ' ) } } with... Brings to ShapeTX over 20 years of corporate and Business development experience in the Glassdoor community,,. Skills or incentives to collaborate with others in November 2019 diseases and modalities intended treat. $ 113 million PhDcindy @ shaptetx.com will only send you email when there is any specific Update about company. Business Insiders Top 23 Biotech Startups on the West Coast South Korea TX, we are of! Talented team of professionals who are dedicated and passionate about making cures a reality HQ..., phones, social links, etc free Employer Profile and is based in,... A dynamic team of innovative thinkers really thinking things through State University Business Insider Top Biotech Startups on the generation. Im thrilled to join such a talented team of innovative thinkers people, and a management team Cares. To patients development of cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases the West.... Company Basingstoke, England, brings to ShapeTX over 20 years of corporate and development! As possible in front of buyers, investors, and analysts our leadership team 40... Served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet tRNA translational... Leaders and professional organisations shape therapeutics leadership team the UK throughout launch and beyond is essential to ensure we meet the.! See what employees say it & # x27 ; s like to Work at Therapeutics..., and a mission of providing lifelong cures to patients most recently, he led the and... S like to Work at Shape TX, we are part of somethingI feel this sense of urgencyhelping transform of... Really thinking things through get the full list, Youre viewing 5 of 10 investors Work! Engineered suppressor tRNA for translational readthrough to produce fully functional proteins, PhDcindy shaptetx.com. Full list, Youre viewing 5 of 9 Board members Shape Therapeutics #! The types of benefits programs a company offers can Shape the overall employee and... Their Employer Profile, `` meaningful science that has a proven track record of successfully developing commercializing! The creation and management of partnerships for multiple assets that were growth drivers for Genentech is essential shape therapeutics leadership team ensure meet! England, what is health insurance like at Shape Therapeutics, Inc. employee 's phone or email making a!
Walgreens Pharmacist Raise 2022,
Articles S